4
Changes in Ownership
ARTIVION, INC. Filed Acc 0001628280-25-053859
SVP, Clinical & MD Affair sold 47,376 shares at an average $45.04 ($2,133,920)
- SVP, Clinical & MD Affair acquired 47,376 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Stanton Marshall S. SVP, Clinical & MD Affair | 2025-11-21 | Option exercise | +20,301 | $18.44 | $374,350 | 65,054 | D: show line 1 in the form |
| Stanton Marshall S. SVP, Clinical & MD Affair | 2025-11-21 | Sale | −14,586 | $44.92 | $655,189 | 50,468 | D: show line 2 in the form |
| Stanton Marshall S. SVP, Clinical & MD Affair | 2025-11-21 | Sale | −5,715 | $45.35 | $259,152 | 44,753 | D: show line 3 in the form |
| Stanton Marshall S. SVP, Clinical & MD Affair | 2025-11-21 | Option exercise | +27,075 | $11.03 | $298,637 | 71,828 | D: show line 4 in the form |
| Stanton Marshall S. SVP, Clinical & MD Affair | 2025-11-21 | Sale | −18,705 | $44.91 | $840,042 | 53,123 | D: show line 5 in the form |
| Stanton Marshall S. SVP, Clinical & MD Affair | 2025-11-21 | Sale | −8,370 | $45.35 | $379,538 | 44,753 | D: show line 6 in the form |
| Open-market sales · 47,376 sh · avg $45.04 · $2,133,920 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Stanton Marshall S. SVP, Clinical & MD Affair | 2025-11-21 | Option exercise · Stock Options (Right to buy) | −20,301 | 0 | D: show line 7 in the form | |||||
| Stanton Marshall S. SVP, Clinical & MD Affair | 2025-11-21 | Option exercise · Stock Options (Right to buy) | −27,075 | 0 | D: show line 8 in the form |
Loading xslF345X05/wk-form4_1764023022.xml…